Medicine information JASCAYD 18mg film-coated tablets

Product code:
W72306001
Quantity:
10
Indicated for:
idiopathic pulmonary fibrosis; progressive pulmonary fibrosis
Route of administration:
oral
Substance:
nerandomilast (antifibrotic agent; selective phosphodiesterase 4B inhibitor)
ATC
L04AA61 — Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Selective immunosuppressants
Nerandomilast is an oral antifibrotic medicine used in adults with idiopathic pulmonary fibrosis or progressive pulmonary fibrosis. These conditions cause gradual scarring of lung tissue and increasingly difficult breathing. Nerandomilast inhibits the PDE4B enzyme, which is involved in inflammatory and fibrotic processes. It may slow the decline in lung function, but it does not cure existing lung scarring.

It is taken as tablets twice a day, as prescribed by a specialist in lung disease. Do not change the dose or stop treatment without medical advice. The doctor will assess lung function, tolerability, weight and general health. Tell the doctor about all medicines and supplements you use, because some may change the amount of nerandomilast in the body.

Side effects may include diarrhoea, nausea, reduced appetite and weight loss. These effects can affect nutrition and hydration, particularly in frail patients. Other digestive symptoms may also occur. If side effects are persistent or troublesome, the doctor may recommend supportive measures or adjust the dose depending on the situation.

Contact the doctor if diarrhoea is severe, you cannot maintain hydration, you lose weight rapidly or your breathing worsens. Seek urgent help for sudden severe breathlessness, chest pain or bluish lips. Tell the doctor if you are pregnant, breastfeeding or planning a pregnancy; information about use in these situations is limited. Attend regular follow-up appointments.

General data about JASCAYD 18mg

Substance:
nerandomilast
Date of latest medicines list:
01-11-2026
Product code:
W72306001
Strength:
18mg
Pharmaceutical form:
film-coated tablets
Quantity:
10
Product type:
Original
Prescription status:
P-RF — Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.

Marketing authorisation

Manufacturer:
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG - GERMANIA
Holder:
BOEHRINGER INGELHEIM INTERNATIONAL GMBH - GERMANIA
Number:
2040/2026/06
Shelf life:
2 years

Strengths available for nerandomilast

  • 18mg
  • 9mg

Warnings:

Major drug interactions

This medicine may have important interactions with other medicines.

Pregnancy warning

Use during pregnancy only on medical advice.

Breastfeeding warning

Use during breastfeeding only on medical advice.

Pediatric warning

Use in children only as recommended in the leaflet or by a doctor.

Teratogenic / fetal risk

This medicine may affect fetal development.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.